9,432 Shares in The Cooper Companies, Inc. $COO Bought by EP Wealth Advisors LLC

EP Wealth Advisors LLC bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund bought 9,432 shares of the medical device company’s stock, valued at approximately $676,000.

A number of other institutional investors have also recently made changes to their positions in the stock. BlackRock Inc. acquired a new position in shares of Cooper Companies in the second quarter worth approximately $1,077,762,000. Generation Investment Management LLP acquired a new stake in Cooper Companies during the 2nd quarter valued at approximately $356,304,000. Wellington Management Group LLP increased its position in Cooper Companies by 332.9% during the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after purchasing an additional 4,756,178 shares during the period. Diamond Hill Capital Management Inc. raised its holdings in Cooper Companies by 479.6% during the 4th quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock worth $269,471,000 after purchasing an additional 2,720,594 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD raised its holdings in Cooper Companies by 58.8% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after purchasing an additional 2,231,568 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Analysts Set New Price Targets

COO has been the topic of a number of analyst reports. Stifel Nicolaus reduced their price objective on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a research note on Friday, June 5th. Piper Sandler set a $86.00 target price on shares of Cooper Companies and gave the stock an “overweight” rating in a research note on Monday, June 1st. Citigroup restated a “neutral” rating and issued a $80.00 target price (up from $76.00) on shares of Cooper Companies in a report on Thursday, August 13th. Needham & Company LLC cut their price target on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. Finally, UBS Group assumed coverage on Cooper Companies in a report on Tuesday, July 28th. They set a “neutral” rating and a $75.00 price target for the company. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $81.64.

Cooper Companies Stock Performance

NASDAQ:COO opened at $75.80 on Tuesday. The company has a fifty day moving average of $72.09 and a 200-day moving average of $71.07. The firm has a market capitalization of $14.78 billion, a P/E ratio of 64.24, a P/E/G ratio of 1.99 and a beta of 0.83. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. Cooper Companies’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, sell-side analysts anticipate that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.